Central Institute for Experimental Medicine and Life Science, Kawasaki, Kanagawa, 210-0821, Japan.
Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, 55905, USA.
Stem Cell Res Ther. 2024 Jun 21;15(1):182. doi: 10.1186/s13287-024-03799-w.
Human hematopoietic stem cell (HSC)-transferred humanized mice are valuable models for exploring human hematology and immunology. However, sufficient recapitulation of human hematopoiesis in mice requires large quantities of enriched human CD34 HSCs and total-body irradiation for adequate engraftment. Recently, we generated a NOG mouse strain with a point mutation in the c-kit tyrosine kinase domain (W41 mutant; NOGW mice). In this study, we examined the ability of NOGW mice to reconstitute human hematopoietic cells. Irradiated NOGW mice exhibited high engraftment levels of human CD45 cells in the peripheral blood, even when only 5,000-10,000 CD34 HSCs were transferred. Efficient engraftment of human CD45 cells was also observed in non-irradiated NOGW mice transferred with 20,000-40,000 HSCs. The bone marrow (BM) of NOGW mice exhibited significantly more engrafted human HSCs or progenitor cells (CD34CD38 or CD34CD38 cells) than the BM of NOG mice. Furthermore, we generated a human cytokine (interleukin-3 and granulocyte-macrophage colony-stimulating factor) transgenic NOG-W41 (NOGW-EXL) mouse to achieve multilineage reconstitution with sufficient engraftment of human hematopoietic cells. Non-irradiated NOGW-EXL mice showed significantly higher engraftment levels of human CD45 and myeloid lineage cells, particularly granulocytes and platelets/megakaryocytes, than non-irradiated NOGW or irradiated NOG-EXL mice after human CD34 cell transplantation. Serial BM transplantation experiments revealed that NOGW mice exhibited the highest potential for long-term HSC compared with other strains. Consequently, c-kit mutant NOGW-EXL humanized mice represent an advanced model for HSC-transferred humanized mice and hold promise for widespread applications owing to their high versatility.
人造血干细胞(HSC)转人化小鼠是探索人类血液学和免疫学的有价值模型。然而,为了充分重现小鼠中的人类造血,需要大量富集的人 CD34 HSC 和全身照射以进行充分的植入。最近,我们生成了一种在 c-kit 酪氨酸激酶结构域中具有点突变的 NOG 小鼠品系(W41 突变体;NOGW 小鼠)。在这项研究中,我们研究了 NOGW 小鼠重建人造血细胞的能力。照射的 NOGW 小鼠在外周血中表现出高水平的人 CD45 细胞植入,即使仅转移了 5000-10000 个 CD34 HSC 也是如此。在未照射的 NOGW 小鼠中,当转移 20000-40000 个 HSC 时,也观察到了有效的人 CD45 细胞植入。NOGW 小鼠的骨髓(BM)中植入的人 HSC 或祖细胞(CD34CD38 或 CD34CD38 细胞)明显多于 NOG 小鼠的 BM。此外,我们生成了一种人细胞因子(白细胞介素 3 和粒细胞-巨噬细胞集落刺激因子)转基因 NOG-W41(NOGW-EXL)小鼠,以实现多谱系重建,并充分植入人造血细胞。非照射的 NOGW-EXL 小鼠在人 CD34 细胞移植后,其人 CD45 和髓系细胞,特别是粒细胞和血小板/巨核细胞的植入水平明显高于非照射的 NOGW 或照射的 NOG-EXL 小鼠。系列 BM 移植实验表明,与其他品系相比,NOGW 小鼠表现出最高的长期 HSC 潜力。因此,c-kit 突变体 NOGW-EXL 人源化小鼠代表了 HSC 转人化小鼠的先进模型,由于其高多功能性,有望得到广泛应用。